Učitavanje...

The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice

Peroxisome Proliferator Activated Receptor (PPAR)-α is a key regulator of lipid metabolism and recent studies reveal it also regulates inflammation in several different disease models. Gemfibrozil, an agonist of PPAR-α, is a FDA approved drug for hyperlipidemia and has been shown to inhibit clinical...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Exp Neurol
Glavni autori: Almad, Akshata, Lash, A. Todd, Wei, Ping, Lovett-Racke, Amy E., McTigue, Dana M.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518476/
https://ncbi.nlm.nih.gov/pubmed/21963672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2011.09.023
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!